NeuroOne Medical Technologies Corp (NASDAQ:NMTC) shares, rose in value on Wednesday, June 18, with the stock price up by 5.80% to the previous day’s close as strong demand from buyers drove the stock to $0.69.
Actively observing the price movement in the last trading, the stock closed the session at $0.65, falling within a range of $0.6414 and $0.7122. The value of beta (5-year monthly) was 0.718. Referring to stock’s 52-week performance, its high was $1.39, and the low was $0.40. On the whole, NMTC has fluctuated by 4.01% over the past month.
With the market capitalization of NeuroOne Medical Technologies Corp currently standing at about $34.26 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2024-Feb-13.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 8.71M, with a low estimate of 1.82M and a high estimate of 1.82M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 1.82M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that NMTC’s technical picture suggests that short-term indicators denote the stock is a Hold on average. However, medium-term indicators have put the stock in the category of 50% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of NMTC currently trading nearly 13.92% and 15.27% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 62.55, while the 7-day volatility ratio is showing 4.48% which for the 30-day chart, stands at 4.09%. Furthermore, NeuroOne Medical Technologies Corp (NMTC)’s beta value is 0.72, and its average true range (ATR) is 0.05.
A comparison of NeuroOne Medical Technologies Corp (NMTC) with its peers suggests the former has fared considerably weaker in the market. NMTC showed an intraday change of 5.80% in last session, and over the past year, it shrunk by -27.93%%.
Data on historical trading for NeuroOne Medical Technologies Corp (NASDAQ:NMTC) indicates that the trading volumes over the past 10 days have averaged 0.17 and over the past 3 months, they’ve averaged 303.36K. According to company’s latest data on outstanding shares, there are 49.82 million shares outstanding.
Nearly 11.99% of NeuroOne Medical Technologies Corp’s shares belong to company insiders and institutional investors own 19.39% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 0.2 million shares as on 2025-05-30, resulting in a short ratio of 0.78. According to the data, the short interest in NeuroOne Medical Technologies Corp (NMTC) stood at 41.00 of shares outstanding as of 2025-05-30; the number of short shares registered in 2025-04-30 reached 0.39 million. The stock has fallen by -16.75% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the NMTC stock heading into the next quarter.
